Compare Neurocrine Biosciences Inc (NBIX) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Prospect Capital Corporation — how do they compare? Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B), while Prospect Capital Corporation trades at $2.27 (market cap $1.14B). The key difference: Neurocrine Biosciences Inc is far larger — about 14.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 21.93% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | PSEC | |
|---|---|---|
Market Cap | $16.46B | $1.14B |
Sector | Health | Financials |
52-Week High | $185.50 | $3.05 |
52-Week Low | $123.10 | $2.11 |
Enterprise Value | $16.48B | — |
Dividend Yield | — | 21.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
